The filing for resale of a significant number of shares by Crinetics Pharmaceuticals Inc could lead to increased liquidity in the market for CRNX shares. However, this action also carries the risk of diluting the value of shares held by current shareholders, as the increase in available shares could lead to a decrease in share price, especially if demand does not match the increased supply. The negative score reflects the potential adverse impact on share price in the short term.